Document:

EX-10.25

 Exhibit 10.25 

CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT IS BOTH NOT MATERIAL AND WOULD LIKELY CAUSE COMPETITIVE HARM
TO THE REGISTRANT IF PUBLICLY DISCLOSED. [***] INDICATES THAT INFORMATION HAS BEEN REDACTED. 

COVID-19 TESTING LABORATORY SERVICES AGREEMENT 

This COVID-19 TESTING LABORATORY SERVICES AGREEMENT (this “Agreement”) is made as of
April 3, 2020 by and between Biodesix, Inc. (“Biodesix”), a Delaware corporation with its usual place of business at 2790 Wilderness Place, Boulder, CO 80301, and Centura Health Corporation
(“Hospital”), a nonprofit corporation with its usual place of business at located at 9100 E. Mineral Circle, Centennial, CO 80112. 

RECITALS 
 A.
Biodesix operates a clinical laboratory that is duly licensed, and is certified under all applicable federal and state statutes and regulations and the Medicare and Medicaid programs, and at which it provides
COVID-19 Droplet Digital PCR testing services (“COVID Testing”, and each test, individually, a “COVID Test”); and 

B. Hospital desires to contract with Biodesix to provide COVID Testing for the Centura facilities listed on Exhibit A
(“Facilities”), and Biodesix and Hospital desire to enter into this Agreement to define their respective rights and responsibilities. 

NOW, THEREFORE, in consideration of the terms, conditions and covenants hereinafter set forth, the parties agree as follows: 

AGREEMENT 
 1. Responsibilities
of Biodesix 
  

	 	a.	 Biodesix shall perform the COVID Testing as requested by the Hospital pursuant to properly completed test
requisition. 

  

	 	b.	 Biodesix will report results to the authorized hospital personnel using its standard report or other required
documentation for the submitted specimen for the COVID Testing. 

  

	 	c.	 Biodesix expects to be required to submit positive specimens to at least State Departments of Health. Negative
samples will be destroyed. Biodesix may retain de-identified remnant specimens for on-going quality assessment and test improvement. 

  
 1 

 2. Responsibilities of Hospital. Hospital shall submit to Biodesix properly completed test
requisition information. Hospital also shall maintain, and furnish to Biodesix upon request, supporting documentation of the physician’s order for the specified COVID Testing services from the ordering physician sufficient to document that any
COVID Testing services performed under this Agreement were reasonable and medically necessary for the diagnosis or treatment of such patient. 
 3. Term
and Termination. 
  

	 	a.	 The term of this Agreement (“Term”) shall be for one (1) year, commencing on the
Effective Date and continuing until the first (1st) anniversary of the Effective Date, and renewing automatically unless terminated in accordance with Section 3.b of this Agreement. 

 

	 	b.	 Either party may terminate this Agreement at any time with or without cause upon thirty (30) days prior
written notice to the other party. 

 4. Billing. 
  

	 	a.	 Throughout the Term of this Agreement, Hospital shall have the sole right to bill third party payers and
collect charges for COVID Testing services ordered by Hospital and performed on specimens collected under this Agreement, except as set forth in Section 4.b for hospital outpatient testing for Medicare patients.

  

	 	b.	 In the event that Hospital requests a COVID Test from Biodesix for a patient who is insured by Medicare and who
is a registered hospital outpatient at the time the specimen is collected (each, a “Medicare Outpatient Test”), Biodesix is required to bill Medicare for such Services. The Hospital shall identify each Medicare Outpatient Test to
Biodesix. 

 5. Payment. 
  

	 	a.	 The payment rate for the COVID Testing shall be [***] per COVID Test. Within the first [***] business days of
each month, Biodesix shall submit a monthly invoice to Hospital for the payment amount for COVID Testing performed during the preceding month. Hospital shall remit payment for such COVID Testing within [***] days of receipt of an invoice to the
Biodesix, Inc. principal address listed above. 

  

	 	b.	 If Hospital disputes anything included in Biodesix’s submission pursuant to
Section 5.b, Hospital shall notify Biodesix, in writing, not less than [***] business days after receipt of such submission. Failure to respond shall be deemed approval of such submission. The parties shall work in good
faith to resolve any disagreements regarding submissions under Section 5.b. 

  

	 	c.	 Hospital may, at Hospital’s discretion, arrange with Biodesix for a fixed
pre-payment retainer for COVID Testing (“Retainer”). Biodesix shall draw down on the Retainer balance billing as per Section 5.a until a balance of [***] of the full
Retainer exists, at which point Hospital will again have the option to top off the balance of the Retainer or move to billing as per Section 5.a. 

  
 2 

 6. Compliance and Warranty. The terms of this Agreement are intended to be in compliance with all
applicable federal, state and local statutes, regulations and ordinances. Each of the parties represents and warrants to the other party that it will comply with all applicable laws, rules and regulations, as they may be amended from time to time,
including, but not limited to, (1) the Health Information Technology for Economic and Clinical Health Act of 2009 (the “HITECH Act”); (2) the Administrative Simplification section of the Health Insurance Portability and
Accountability Act of 1996, as codified at 42 U.S.C. §1320d through d-8 (“HIPAA”); (3) the requirements of any regulations promulgated under either the HITECH Act or HIPAA, including,
without limitation, the federal privacy regulations as contained in 45 CFR Parts 160 and 164 (the “Federal Privacy Regulations”), the federal security standards as contained in 45 CFR Parts 160, 162 and 164 (the “Federal
Security Regulations”), and the federal standards for electronic transactions contained in 45 CFR Parts 160 and 162 (the “Federal Electronic Transactions Regulations”); (4) the federal Physician Self-Referral Law
(42 U.S.C. § 1395nn), the regulations promulgated thereunder and similar state physician self-referral laws and regulations; (5) the federal Medicare/Medicaid Anti-Kickback Law (42 U.S.C. §
1320a-7b), the regulations promulgated thereunder and similar state anti-kickback laws and regulations; and (6) the Eliminating Kickbacks in Recovery Act (18 U.S.C. § 220), the regulations
promulgated thereunder and similar state laws and regulations. 
 7. Governing Law. This Agreement shall be governed by and construed according to
the laws of the State of Colorado without regard to the conflict of laws provisions thereof. 
 8. Insurance. During the performance of this
Agreement, the Hospital shall, at its own expense, carry and maintain insurance at levels sufficient to support the obligations in this Agreement. The Hospital shall, at Biodesix’s written request, furnish to Biodesix a certificate indicating
that such insurance is in force. 
 9. Independent Contractor. Biodesix is, and shall at all times be deemed to be, an independent contractor and
shall carry out the responsibilities required of it by the terms of this Agreement. This Agreement shall not be construed as creating the relationship of employer and employee, or principal and agent, between Biodesix and Hospital or any of
Hospital’s employees, agents, consultants, or subcontractors. Each party assumes exclusively the responsibility for the acts of their respective employees, agents, consultants, or subcontractors as they relate to any Services provided under
this Agreement. 
 10. Indemnification. Each party shall defend, indemnify and hold harmless the other party and such party’s directors,
officers, employees, affiliates, and agents from and against any and all third party claims, losses, damages, costs, expenses or liabilities to the extent arising out of its obligations pursuant to this Agreement, except to the extent such claims,
losses, damages, costs, expenses or liabilities arise out of the gross negligence or willful misconduct of party seeking such indemnification, its employees or agents. The provisions of this Section 10 shall survive the
termination of this Agreement. The party requesting to be indemnified must place such a demand, in writing, to the other party within [***] days of its notice of the claim. The indemnified party must cooperate fully with the investigation and
defense of the claim or suit, and may not take any action which will prejudice the claim or suit. 

  
 3 

 11. Entire Agreement. This Agreement constitutes the entire agreement between the parties hereto with
respect to the subject matter hereof, and shall supersede all previous negotiations, commitments, and writings. This Agreement shall not be amended, released, discharged, changed or modified except by a written instrument signed by a duly authorized
representative of each of the parties. 
 12. Amendments. No modifications of or amendment to this Agreement shall be effective or binding on either
party unless mutually agreed to in writing signed by both parties. 
 13. Notice. All notices required or permitted to be given under this Agreement
shall be in writing and shall be (a) delivered personally, (b) sent by certified mail, or (c) sent by a nationally-recognized courier guaranteeing next-day delivery, to the recipients below. The
parties agree that changes to the addresses below for receipt of notices under this Section may be effected by a letter signed by the relevant party and does not require an amendment to this Agreement signed by all parties. 

If to Sponsor: 
 Biodesix, Inc. 

2970 Wilderness Place 
 Suite 100 

Boulder, Colorado 80301 
 Attention: Legal and Regulatory Affairs

 LegalAffairs@Biodesix.com 
 If to the Hospital: 

Centura Health 
 9100 E Mineral Circle 

Centennial, CO 80122 
 Laboratory 3rd Floor 

[***] 
 [SIGNATURE PAGE FOLLOWS] 

  
 4 

 IN WITNESS WHEREOF, the parties have executed this Agreement as of the day and year first
written above. 
  

			
	BIODESIX, INC.
		
	By:	 	 /s/ Robin Harper Cowie

	Name:	 	 Robin Harper Cowie

	Title:	 	 CFO

	
	CENTURA HEALTH CORPORATION
		
	By:	 	 /s/ Ramy Hanna

	Name:	 	 Ramy Hanna

	Title:	 	 SVP Shared Services

  
 5EX-10.26

 Exhibit 10.26 

CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT IS BOTH NOT MATERIAL AND WOULD LIKELY CAUSE COMPETITIVE HARM
TO THE REGISTRANT IF PUBLICLY DISCLOSED. [***] INDICATES THAT INFORMATION HAS BEEN REDACTED. 
 FIRST AMENDMENT TO COVID-19 TESTING LABORATORY SERVICES AGREEMENT 
 This first amendment (“First Amendment”) is made
effective as of April 23, 2020 (“Amendment Effective Date”) and shall serve to modify that certain COVID-19 Testing Laboratory Services Agreement dated April 3, 2020
(“Agreement”) by and between Centura Health Corporation (“Hospital”) and Biodesix, Inc. (“Biodesix”). 

Background 
 Biodesix entered into the
Agreement to provide Hospital with COVID-19 Testing services. Parties wish to amend Section 5 (Payment) of the Agreement. 

NOW, THEREFORE, in consideration of the foregoing and the promises and conditions of this First Amendment, the parties agree as follows: 

 

	1.	 All capitalized terms in this First Amendment shall have the same meaning as defined in the Agreement.

  

	2.	 The Agreement shall be amended as follows: 

 

	 	A.	 DELETE AND REPLACE: Item b. of Section 1 (Responsibilities of Biodesix) of the Agreement is hereby deleted
in its entirety and replaced with the following: 

 “(i) Biodesix will pickup
pre-operative test specimens at the previously agreed upon collection times per Hospital collection siteas as listed on Table 1 attached as Exhibit A of this First Amendment. Table 1 may be replaced
through amendment upon mutual agreement between Hospital and Biodesix. 
 (ii) Provided samples are available at the proper times and their
delivery is not subject to any exceptions listed in Section 3c, Biodesix will guarantee to provide test results for at least [****] of tests by 12:00 p.m. on the day following pickup by Biodesix from each Hospital collection site. Biodesix will
report results to the authorized Hospital personnel using its standard report or other required documentation for the submitted specimen for COVID Testing.” 
  

	 	B.	 ADDITION: To the end of Section 2 (Responsibilities of Hospital): 

“Hospital shall inform Biodesix of any substantial change to the specimen collection protocols that could impact performance of COVID
Testing.” 
  

	 	C.	 ADDITION: A new Item c. to Section 3 (Term and Termination): 

“Hospital may terminate this Agreement immediately should Biodesix fail to comply to provide the promised percentage of test results
within the required 

  
 Confidential Information 

Biodesix-Centura Health (Amd to COVID-19 Testing Agreement) 

(04232020) 

 
timeframe noted in 1.b.ii. and such non-compliance is not a result of Hospital’s failure to provide samples for testing
pick-up by the agreed upon timeframes noted in Section lb.i. Biodesix will be excused from its obligations under this Agreement to the extent that performance is delayed or prevented by forces beyond its
control, including, without limitation, strikes, work stoppages, accidents, acts of war or terrorism, civil or military disturbances, nuclear or natural catastrophes or acts of God, and interruptions, loss or malfunctions of utilities, as well as,
additional restrictions placed on commerce as a result of COVID (or any other disease outbreak), isolated Courier delivery delays (which result from traffic or automobile related issues). Biodesix and Hospital will work together in a good faith
effort to adjust the pick-up and delivery times should either party deem it necessary. If such termination occurs, Hospital shall pay Biodesix for all completed tests that it has yet to be compensated for up
to the effective date of termination. Upon such termination, Biodesix will provide Hospital with a final report of all outstanding unpaid tests.” 
  

	 	D.	 DELETE AND REPLACE: All of Section 5 (Payment) of the Agreement is hereby deleted in its entirety and
replaced with the following: 

 “Hospital shall agree to purchase an intial quantity of [***] COVID Testing tests.
Hospital shall arrange with Biodesix for a fixed pre-payment retainer with an initial balance (“Retainer”) equal to the value of [***] COVID Testing tests. The cost per test shall be [***]
(“Price”) and the Retainer balance shall be [***]. The Retainer shall be drawn down by Biodesix on a per test basis at the Price until a balance of [***] of the Retainer remains [***]. At such time, Hospital will assess its
projected future needs for such testing based on then-current trends and agrees to purchase additional COVID Testing tests in increments of up to [***] as deemed necessary by such trending assessments. 

The Retainer may be increased at Hospital’s sole discretion at the Price for each additional
pre-paid test. The Price shall be reviewed by Biodesix and Hospital after six (6) months.” 
  

	3.	 This First Amendment, together with the Agreement, constitute the entire agreement between the parties with
respect to the subject matter contained therein, and together, supersede and replace any and all prior and contemporaneous understands, arrangements and agreements, whether oral or written, with respect to the subject matter. 

 

	4.	 Except as provided hereinabove, the parties hereby confirm and ratify that all terms and conditions of the
Agreement, as heretofore amended, are in full force and effect and shall continue to apply, as amended by this First Amendment. 

  

	5.	 This First Amendment may be executed in two or more identical counterparts, each of which shall be deemed to be
an original and all of which taken together shall be deemed to constitute the First Amendment when a duly authorized representative of each arty has signed a counterpart. Each party agrees that the delivery of the First Amendment by facsimile or
electronic transmission shall have the same force and effect as delivery of 

  
 2 

Confidential Information 
 Biodesix-Centura Health (Amd to
COVID-19 Testing Agreement) 
 (04232020) 

	 	
original signatures and that each party may use such facsimile or electronic signatures as evidence of the execution and delivery of the First Amendment by all parties to the same extent that an
original signature could be used. 

 SIGNATURE PAGE FOLLOWS 

  
 3 

Confidential Information 
 Biodesix-Centura Health (Amd to
COVID-19 Testing Agreement) 
 (04232020) 

 IN WITNESS WHEREOF, the parties have caused this First Amendment to be executed in multiple counterparts by
their duly authorized representatives as of the Amendment Effective Date. 
  

									
	Centura Health Corporation	 		 	Biodesix Inc.
					
	By:	 	 /s/ Ramy Hanna
	 		 	By:	 	 /s/ Robin Harper Cowie

					
	Name:	 	 Ramy Hanna
	 		 	Name:	 	 Robin Harper Cowie

					
	Title:	 	 SVP Shared Services
	 		 	Title:	 	 CFO

  
 4 

Confidential Information 
 Biodesix-Centura Health (Amd to
COVID-19 Testing Agreement) 
 (04232020)

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00314-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00314-of-00352.parquet"}]]